🇺🇸 Pain-Relief Medication in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 10

Most-reported reactions

1. Abdominal Sepsis — 1 report (10%)
2. Diarrhoea — 1 report (10%)
3. Erythema — 1 report (10%)
4. Infection — 1 report (10%)
5. Malignant Neoplasm Progression — 1 report (10%)
6. Pain Of Skin — 1 report (10%)
7. Post Procedural Sepsis — 1 report (10%)
8. Pruritus — 1 report (10%)
9. Reaction To Colouring — 1 report (10%)
10. Renal Failure Acute — 1 report (10%)

Source database →

Frequently asked questions

Is Pain-Relief Medication approved in United States?

Pain-Relief Medication does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Pain-Relief Medication in United States?

Parc de Salut Mar is the originator. The local marketing authorisation holder may differ — check the official source linked above.